Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster presentation 1

502 - Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival

Date

19 Dec 2015

Session

Poster presentation 1

Presenters

Sumadi Lukman Anwar

Citation

Annals of Oncology (2015) 26 (suppl_9): 8-15. 10.1093/annonc/mdv518

Authors

S.L. Anwar1, U. Lehmann2, T. Krech2, B. Hasemeier2, E. Schipper2, N. Schweitzer3, A. Vogel4, H. Kreipe2

Author affiliations

  • 1 Surgery, Gadjah Mada University/Dr. Sardjito General Hospital, 55281 - Yogyakarta/ID
  • 2 Pathology, Hannover Medical School, 30625 - Hannover/DE
  • 3 Gastroenterology, Hepatology, And Endocrinology, Hannover Medical School, 30625 - Hannover/DE
  • 4 Gastroenterology, Hepatology And Endokrinology, Hannover Medical School, 30625 - Hannover/DE
More

Resources

Abstract 502

Aim/Background

To find a prognostic biomarker using dysregulation of DNA methylation at imprinted loci in human hepatocellular carcinoma.

Methods

Quantitiative DNA methylation analysis at all imprinted loci in primary HCC samples, adjacent peri-tumoral tissues, hepatocellular adenoma, and healthy liver.

Results

We found frequent and extensive DNA methylation aberrations at many imprinted loci in HCC. Unsupervised cluster analysis of DNA methylation patterns at imprinted loci revealed subgroups of HCCs with moderate and severe loss of methylation. Hypomethylation at imprinted loci correlated significantly with poor overall survival (log rank test, p = 0.02). Demethylation at imprinted loci was accompanied by loss of methylation at LINE-1, a commonly used marker for global DNA methylation levels (p < 0.001). In addition, we found that loss of methylation at imprinted loci correlated with the presence of a CTNNB1 mutation (Fisher exact test p = 0.03). Re-analysis of publically available genome-wide methylation data sets confirmed our findings. The analysis in benign liver tumors (hepatocellular adenoma / HCA and focal nodular hyperplasia / FNH), the corresponding adjacent liver tissues, and healthy liver tissues showed that aberrant DNA methylation at imprinted loci is specific for the process of malignant transformation.

Conclusions

Our analyses demonstrate frequent and widespread DNA methylation aberrations at imprinted loci in human HCC identifying a hypomethylated subgroup of patients with shorter overall survival.

Clinical trial identification

not applicable

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings